BIOCOMO
Biocomo, Inc. is a drug discovery venture that works on research and development of new vaccines in collaboration with Professor Tetsuya Nosaka , Infectious Disease Control Medicine and Molecular Genetics, Mie University Graduate School of Medicine.
BIOCOMO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-05-30
Address:
Mie, Mie, Japan
Country:
Japan
Website Url:
http://www.biocomo.jp
Status:
Active
Contact:
059-392-7333
Technology used in webpage:
Nginx YouTube SAKURA Internet ASAHINET DNS Gehirn
Similar Organizations
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
Sphaera Pharma
Sphaera Pharma is engaged in the discovery and development of pharmaceutical drugs.
Current Employees Featured
Masayuki Fukumura Representative Director and Founder @ BioComo
Representative Director and Founder
Mitsuhiro Fujita CFO @ BioComo
CFO
Founder
Official Site Inspections
http://www.biocomo.jp Semrush global rank: 5.27 M Semrush visits lastest month: 1.56 K
- Host name: www1564.sakura.ne.jp
- IP address: 219.94.163.204
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "BioComo"
BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
代表取締役ご挨拶 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
BioComo - Crunchbase Company Profile & Funding
Contact Email info@biocomo.jp Phone Number +81 059-392-7333 Biocomo, Inc. is a drug discovery venture that works on research and development of new vaccines in collaboration …See details»
三重大・バイオコモの経鼻ワクチンの実用化に向けて
Nosaka@doc.medic.mie-u.ac.jp または. バイオコモ株式会社. 代表取締役 福村正之. TEL： 059-392-7333. E-mail ： m-fukumura@biocomo.jp. 遺伝子とタンパク質. の両者を運搬. 1See details»
バイオベンチャー ダイレクトリー バイオコモ株式会社
技術＆事業概要 バイオコモの独自技術によりヒトパラインフルエンザ2型ウイルス(hpiv2)ベクターを基に開発され、5’-ppp-rivと命名された不活化ウイルスベクタープラットホーム技術を …See details»
BioComo Company Profile - Office Locations, Competitors ... - Craft
BioComo Incorporation is a biotech company engaged in the development of biological vaccines. Its technology can be applied to the production of vaccines for the prevention of infections …See details»
バイオコモ株式会社 | InfoBase
バイオコモ株式会社. 会社概要. 遺伝子導入用ベクターの構築・製造に関するコンサルティングや生物医薬品・バイオ製品の研究開発に関するコンサルティングを行っています。See details»
会社概要 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
BioComo - Golden
BioComo is a Mie, Japan-based biotech company engaged in the development of vaccines for cancer and infectious diseases. ... Contents. biocomo.jp. Is a. Company. Organization. …See details»
Mie University and BioComo Inc. Team up to Develop Nasal Spray …
Apr 25, 2024 For more information, please visit https://www.mie-u.ac.jp. Contacts: koho@ab.mie-u.ac.jp. About BioComo Inc. BioComo is a biotech company founded in May …See details»
バイオコモ株式会社 | 2024年08月06日更新 | SalesNow DB
バイオコモ株式会社の企業概要ページです。バイオコモ株式会社の事業内容は三大学と共同でバイオ医薬品のr&dを行う企業です。本社の住所は三重県三重郡菰野町大字菰野1325番地で …See details»
Joint Statement of Tripartite Collaboration - 啟弘生物科技 ...
Apr 25, 2024 【Joint Statement of Tripartite Parties 】 Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the …See details»
バイオコモ株式会社の会社情報と資金調達 | NIKKEI COMPASS
【nikkei compass】バイオコモ株式会社は、ヒトパラインフルエンザウイルスの特性を活かし、ワクチン用ベクター技術の開発などを行う企業。See details»
BioComo - Overview, News & Similar companies | ZoomInfo.com
BioComo contact info: Phone number: +81 593927333 Website: www.biocomo.jp What does BioComo do? BioComo, a biotech company founded at Mie Prefecture Japan in May 2008, is …See details»
バイオコモ - STARTUP DB｜スタートアップデータベース
社名 バイオコモ 設立日 2007.05.30 (18年目) 大学発 三重大学 住所 〒510-1233 三重県三重郡菰野町大字菰野1325番地See details»
【菰野町】菰野町にある企業「バイオコモ株式会社」・三重大学 …
2020年7月27日、三重大学は菰野町にある企業「バイオコモ株式会社」と米国の製薬会社「メディシノバ社」と新型コロナウイルスワクチンの国際共同開発を行うことを発表しました。三 …See details»
MediciNova Announces SARS-CoV-2 Vaccine Joint Development …
Jul 27, 2020 BioComo, a biotech company founded at Mie Prefecture Japan in May 2008, is developing cutting-edge technology platforms for creating the novel and predominant vaccine …See details»
沿革 – バイオコモ株式会社 - BioComo
Jul 10, 2019 Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. …See details»
GenScript and BioComo Join Forces to Accelerate Novel Intranasal …
Dec 1, 2021 the corporate name, BioComo, and the leading vaccine carrier which is derived. from the recombinant human parainfluenza virus 2 (hPIV2) vectors. BioComo is. dedicated to …See details»
プラットフォーム・技術 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»